City of Hope establishes mobile cancer prevention and screening program

Rural Appalachian lung cancer screening initiative expands screening access

UVA Cancer Center, Appalachian Community Cancer Alliance, and Buchanan General Hospital have teamed up to make getting screened for lung cancer easier for residents of rural Virginia and West Virginia.

December 06, 2024

Vol.50 No.45

Clinical Roundup

Home testing kits, coordinated outreach improve CRC screening rates

Colorectal cancer screening is an effective tool for catching the disease early when it’s most treatable, yet it is underutilized in patient populations who receive primary care at federally qualified health centers.

December 06, 2024

Vol.50 No.45

Clinical Roundup

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Researchers at City of Hope found that taking white button mushroom pills reduces a class of immune cells called myeloid-derived suppressor cells, which has been linked to cancer development and spread.

November 22, 2024

Vol.50 No.44

Clinical Trials & Tribulations

How we improved the treatment of Hodgkin lymphoma

Hodgkin lymphoma has long been a model disease in the field of oncology—one of the first diseases we learned to cure with radiation and ultimately chemotherapy.

Mainz Biomed and Thermo Fisher collaborate to develop next-gen global CRC screening product

Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer, announced a collaborative agreement with Thermo Fisher Scientific Inc. through its subsidiary Life Technologies Corporation.

November 15, 2024

Vol.50 No.43

Clinical Trials & Tribulations

A study measures the long-term downside of prostate cancer screening
A paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment

In this week’s issue of JAMA Oncology, there is an important paper that provides information concerning the long-term adverse effects and complications of prostate cancer screening and treatment. xxx:more

November 08, 2024

Vol.50 No.42

By Otis W. Brawley

City of Hope establishes mobile cancer prevention and screening program

YOU MAY BE INTERESTED IN

Rural Appalachian lung cancer screening initiative expands screening access

Home testing kits, coordinated outreach improve CRC screening rates

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

How we improved the treatment of Hodgkin lymphoma

Mainz Biomed and Thermo Fisher collaborate to develop next-gen global CRC screening product

A study measures the long-term downside of prostate cancer screening
A paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment

Renew today!

Subscriber content

Never miss an issue!

Login

City of Hope establishes mobile cancer prevention and screening program

YOU MAY BE INTERESTED IN

Rural Appalachian lung cancer screening initiative expands screening access

Home testing kits, coordinated outreach improve CRC screening rates

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

How we improved the treatment of Hodgkin lymphoma

Mainz Biomed and Thermo Fisher collaborate to develop next-gen global CRC screening product

A study measures the long-term downside of prostate cancer screeningA paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment

Never miss an issue!

Login

A study measures the long-term downside of prostate cancer screening
A paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment